Direct-acting antivirals
64 articles
Public Reimbursement Policies in Canada for Direct-Acting Antiviral Treatment for Hepatitis C
Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study More
Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
An article in 2023 issue of TAGline explores how to reimagine HCV elimination strategies now that intellectual property is no longer restricting access to generic cures. More
Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
An article in 2023 issue of TAGline explores how to reimagine HCV elimination strategies now that intellectual property is no longer restricting access to generic cures. More
Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
An article in 2023 issue of TAGline explores how to reimagine HCV elimination strategies now that intellectual property is no longer restricting access to generic cures. More
Long-Term Benefit of DAAs on Gut Dysbiosis and Microbial Translocation
Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection More
